Moderators: Dimitrios Filippiaidis, MD, PhD, MSc, EBIR, National and Kapodistrian University of Athens; Sean Merrill Tutton, MD, UCSD Health

Neuro Palliation, David Prologo, MD, FSIR, Emory University School of Medicine/Emory Healthcare
Thoracic Palliation, Vlasios Sotirchos, MD, Memorial Sloan Kettering Cancer Center
GI Palliation, Steven Huang, MD, University of Texas MD Anderson Cancer Center
MSK Palliation, Alexis Kelekis, MD, PhD, EBIR, FCIRSE, FSIR, National and Kapodistrian University of Athens
Tumor Board, All session faculty listed above

Lunch and Industry Symposium presented by Interventional Oncology at Johnson & Johnson (INTO) - Novel Intratumoral Cancer Treatments and the Expanding Role of the Interventional Radiologist

Moderator: Kamyar Farahi, PhD, Head, Scientific Engagement & Education, Global Scientific Affairs, INTO at J&J

Harnessing Pharma and Medical Technology Expertise to Eliminate Cancer through Intratumoral Treatments, Hannah McEwen, PhD, Vice President, Engineering Sciences, INTO at J&J
Understanding Unmet Needs in Cancer Treatment and Expanding IR’s Role in the Evolving Landscape, Robert Short MD, PhD, Vascular Interventional Radiologist, Associate Professor, Radiology, Surgery, Biomedical Engineering, Wright State University, Boonshoft School of Medicine

This session was recorded as a component of the 2025 Annual Scientific Meeting in Las Vegas. This session was from Friday, January 31st.

Moderators: Alexander Lam, MD, University of California, San Francisco; Giovanni Mauri, MD, IRCCS Ospedale Galeazzi - Sant'Ambrogio

Thyroid Nodules: Diagnosis & Management, Elizabeth Holt, MD, PhD, University of California, San Francisco
Head & Neck Anatomy: CT-US Correlation, Tara Henrichsen, MD, Mayo Clinic
Surgical Management of Thyroid Lesions, Julie Ann Sosa, MD, MA, FACS, FSSO, University of California, San Francisco
Current Evidence for Ablation for Thyroid Lesions, Alexander Lam, MD, University of California, San Francisco 
Thyroid Lesion Ablation: Guidelines, Screening, Patient Selection, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
RFA vs. MWA vs. Cryo vs. Laser, Gary Tse, MD, University of California, Los Angeles

Moderators: Giovanni Mauri, MD, IRCCS Ospedale Galeazzi - Sant'Ambrogio; Gary Tse, MD, UCLA

Parathyroid Ablation: Tip and Tricks, Giovanni Mauri, MD, IRCCS Ospedale Galeazzi - Sant'Ambrogio
Neck Soft Tissue and Osseous Tumor Ablation, Majid Khan, MBBS, MD, Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Hospital Division of Neuroradiology and Interventional Radiology
Tumor Board, All session faculty listed above; Matthew Abad-Santos, MD, University of Washington; Alexander Lam, MD, University of California, San Francisco; John Schmitz, MD, Mayo Clinic

Moderators: Brian Park, MD, OHSU; Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center

Pros and Cons of Ablation for Low Grade Thyroid Lesions, Fourat Ridouani, MD, Memorial Sloan Kettering Cancer Center
Post-Ablation or Post- Surgical Thyroid Cancer Recurrence, Giovanni Mauri, MD, IRCCS Ospedale Galeazzi - Sant'Ambrogio
Embolization of Goiter and Thyroid Cancer, Alan Alper Sag, MD, University of Miami Miller School of Medicine
Complications and How to Mitigate Them, Timothy Huber, MD, MD Anderson Cancer Center
Practice & Business Development, Alexander Lam, MD, University of California, San Francisco

This session was recorded as a component of the 2025 Annual Scientific Meeting in Las Vegas. This session was from Sunday morning, February 2nd. This session is supported by an educational grant from Guerbet.

Moderators: David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital; Gloria Hwang, MD, FSIR, Stanford University

Building a Multidisciplinary Melanoma Program, Robert Adamo, MD, Thomas Jefferson University Hospital
Relative Advantages of Chemoembolization and Immunoembolization, David J. Eschelman, MD, FSIR, Sidney Kimmel Medical College of Thomas Jefferson University, Thomas Jefferson University Hospital
Y90 with or without Immunotherapy, Gloria Hwang, MD, FSIR, Stanford University
Ablative Techniques with or without Immunotherapy, Chenyang Zhan, MD, PhD, Memorial Sloan Kettering Cancer Center
Percutaneous Hepatic Perfusion with Melphalan, Alexander Villalobos, MD, University of North Carolina Chapel Hill

Moderators: Peiman Habibollahi, MD, MD Anderson Cancer Center; Nishita Kothary, MD, Stanford School of Medicine

Surgical Techniques and Estimation of Functional Liver Reserve, Eric Nakakura, MD, PHD, University of California San Francisco
PVE: Which Embolic to Choose? Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, INCA Brazilian National Cancer Institute
Total Venous Deprivation, Francesco de Cobelli, MD, San Raffaele Hospital and Salute University
Radiation Lobectomy: Updates and Trials in Progress, Resmi Charalel, MD, MPH, Weill Cornell Medicine

Lunch and Industry Symposium presented by Siemens Healthineers and Varian, a Siemens Healthineers Company - Connecting the Power of Collaboration, Imaging, and Therapy: Delivering the Future of Palliative Patient Care

Moderator: Theresa Caridi, MD FSIR, University of Alabama Director of Medical Affairs, Varian Medical Systems

Breaking the Ice: A Review of Musculoskeletal Cryoablation Literature, Merve Ozen, MD, Mayo Clinic Arizona
Harnessing Imaging and Therapy to Improve Workflow and Drive Patient Outcomes, Scott Genshaft, MD, UCLA Health
The Future of Evidence in Multidisciplinary Oncologic Pain Palliation, Jack Jennings, MD, PhD, FACR, FSIR, FCIRSE, Washington University
Improving Patient Satisfaction through Multidisciplinary Care: The Intersection of Radiation and Interventional Oncology, Dee Khuntia, MD, FASTRO, Senior Vice President, Chief Medical Officer, Varian Medical Systems